PLC Systems' RenalGuard to be Demonstrated at Cardiology Meetings in Germany and Israel
MILFORD, Mass., April 13, 2012 /PRNewswire/ -- PLC Systems Inc. (OTC: PLCSF), a company focused on innovative medical device technologies, today announced that its innovative RenalGuard System™ is being demonstrated at two major cardiology meetings: Jahrestagung der DGK, the 78th Annual Congress of the German Society of Cardiology, April 11-14, 2012 in Mannheim, Germany, and the 59th Annual Conference of the Israel Heart Society, April 16-17, 2012 in Tel-Aviv, Israel. Both ACIST Medical Systems, PLC's distributor in Germany, and A.M.I. Technologies, its distributor in Israel, are exhibiting RenalGuard in their booths at the events, demonstrating its ease of use along with scientific data supporting its efficacy to potential customers. More than 8,000 clinicians and professionals are expected to attend the two conferences.
Mark R. Tauscher, president and chief executive officer of PLC Systems, said, "These conferences are premier cardiovascular events in Germany and Israel, two major new markets for RenalGuard®. RenalGuard is being displayed in both the ACIST and A.M.I. booths at these events, providing important exposure of our new technology to global knowledge leaders, and current and potential customers."
In March 2012, A.M.I. became the exclusive distributor of RenalGuard in Israel, and secured Ministry of Health approval to market and distribute RenalGuard in the country. In October 2011, ACIST became the exclusive distributor of PLC's RenalGuard in Germany and France, the two largest countries in the European Union.
About PLC Systems
PLC Systems Inc., headquartered in Milford, Mass., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC's newest product, RenalGuard, has been developed to help prevent the onset of Contrast-Induced Nephropat